Aiming at the Right Targets on Drug Price Reform.

Stacie B Dusetzina

Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2024)

A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.

Keyphrases

end stage renal disease
primary care
healthcare
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
drug induced